MetaCap

CRISPR Therapeutics Statistics

NASDAQ: CRSPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.10+0.17 (+0.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CRISPR Therapeutics by the numbers

CRISPR Therapeutics has a market capitalization of $3.79 billion based on 97.00M shares outstanding. With trailing EPS of $-4.73, CRISPR Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.9% below its 50-day average and 25.2% below its 200-day average.

Average daily trading volume is 1.74M shares, or about $68.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CRSP valuation vs. peer median

CRSP compared with the median of 8 peer companies
MetricCRSPPeer medianDifference
Market cap$3.79B$3.07B+23%
Avg. volume1.74M2.12M-18%

Peer median across 8 companies: TARS, RLAY, IOVA, ADPT, DNLI, VCEL, ADMA, BEAM.

Valuation

Price / sales (latest FY)
1,080.55
EPS (TTM)
$-4.73

Price and trading

Previous close
38.93
Open
38.18
Day range
38.18 – 40.17
52-week range
38.15 – 63.45
52-week change
-22.16%
Beta
—
Volume
3.32M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
3.79B
Forward Pe
-10.61
Eps
-4.73
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
63.45
Week52 Low
38.15
Avg Volume
1.74M
Shares Outstanding
97.00M
Ma50
50.71
Ma200
52.27
Earnings Date
Nov 2, 2026
Pct From52w High
-38.38%
Pct From52w Low
2.49%

Related